Cargando…
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
The recent past has seen impressive progress in the treatment of various malignancies using immunotherapy. One of the most promising approaches involves immune checkpoint inhibitors. However, the clinical results with these agents have demonstrated variability in the response. Pancreatic cancer, in...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423142/ https://www.ncbi.nlm.nih.gov/pubmed/30886310 http://dx.doi.org/10.1038/s41598-019-41251-9 |